| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Lucy J Troup, Jeremy A Andrzejewski, Jacob T Braunwalder, Robert D Torrenc. The relationship between cannabis use and measures of anxiety and depression in a sample of college campus cannabis users and non-users post state legalization in Colorado. PeerJ. vol 4. 2020-09-29. PMID:27957402. |
results indicate a relationship between casual cannabis use and scoring highly for depressive symptomatology on the center for epidemiologic studies depression scale. |
2020-09-29 |
2023-08-13 |
human |
| Alline C Campos, Manoela V Fogaça, Franciele F Scarante, Sâmia R L Joca, Amanda J Sales, Felipe V Gomes, Andreza B Sonego, Naielly S Rodrigues, Ismael Galve-Roperh, Francisco S Guimarãe. Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders. Frontiers in pharmacology. vol 8. 2020-09-29. PMID:28588483. |
beneficial effects of cannabidiol (cbd) have been described for a wide range of psychiatric disorders, including anxiety, psychosis, and depression. |
2020-09-29 |
2023-08-13 |
Not clear |
| Shawn Y Forrester, Nusrat Jaha. Depression Onset in Long-term Adolescent Cannabinoid Use: A Neurobiological Review. Cureus. vol 12. issue 4. 2020-09-28. PMID:32455076. |
escalating cannabis use may be linked to decreased motivation and anhedonia, which are symptoms of depression. |
2020-09-28 |
2023-08-13 |
human |
| Shawn Y Forrester, Nusrat Jaha. Depression Onset in Long-term Adolescent Cannabinoid Use: A Neurobiological Review. Cureus. vol 12. issue 4. 2020-09-28. PMID:32455076. |
the main issue regarding depression within the context of cannabis use is whether or not there is a neurobiological basis linking the two variables. |
2020-09-28 |
2023-08-13 |
human |
| Shawn Y Forrester, Nusrat Jaha. Depression Onset in Long-term Adolescent Cannabinoid Use: A Neurobiological Review. Cureus. vol 12. issue 4. 2020-09-28. PMID:32455076. |
data were included from studies that satisfied the following criteria: (i) published within the last 10 years (older studies were included based on relevance), (ii) on adolescent subjects (animal or human), (iii) published in english, (iv) journal articles, systematic reviews, meta-analyses, clinical trials, observational studies (animal or human), (v) on subjects who had unipolar depression with no comorbidities, and (vi) on subjects who used cannabis [with no confounding variables such as the use of ethanol, nicotine, cocaine, lysergic acid diethylamide (lsd), and heroin; and no medical conditions such as comorbid psychosis, mania, or autism]. |
2020-09-28 |
2023-08-13 |
human |
| Natalia Szejko, Carolin Fremer, Kirsten R Müller-Vah. Cannabis Improves Obsessive-Compulsive Disorder-Case Report and Review of the Literature. Frontiers in psychiatry. vol 11. 2020-09-28. PMID:32848902. |
here we present the case of a 22-year-old male patient, who suffered from severe ocd since childhood and significantly improved after treatment with medicinal cannabis with markedly reduced ocd and depression resulting in a considerable improvement of quality of life. |
2020-09-28 |
2023-08-13 |
Not clear |
| Rachel L Tomko, Nathaniel L Baker, Caitlyn O Hood, Amanda K Gilmore, Erin A McClure, Lindsay M Squeglia, Aimee L McRae-Clark, Susan C Sonne, Kevin M Gra. Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder. Psychopharmacology. vol 237. issue 2. 2020-08-04. PMID:31712969. |
depression is common among individuals with cannabis use disorder (cud), particularly individuals who present to cud treatment. |
2020-08-04 |
2023-08-13 |
Not clear |
| Jesse D Kosiba, Stephen A Maisto, Joseph W Ditr. Patient-reported use of medical cannabis for pain, anxiety, and depression symptoms: Systematic review and meta-analysis. Social science & medicine (1982). vol 233. 2020-07-29. PMID:31207470. |
patient-reported use of medical cannabis for pain, anxiety, and depression symptoms: systematic review and meta-analysis. |
2020-07-29 |
2023-08-13 |
Not clear |
| Jesse D Kosiba, Stephen A Maisto, Joseph W Ditr. Patient-reported use of medical cannabis for pain, anxiety, and depression symptoms: Systematic review and meta-analysis. Social science & medicine (1982). vol 233. 2020-07-29. PMID:31207470. |
certifications for medical cannabis are generally restricted to a small number of specific medical conditions, yet patients frequently report symptoms of pain, anxiety, and depression as reasons for use. |
2020-07-29 |
2023-08-13 |
Not clear |
| Andrea Lukács, Małgorzata Wasilewska, Olha Sopel, Marie-Pierre Tavolacci, Beatrix Varga, Marta Mandziuk, Olena Lototska, Péter Sasvári, Halyna Krytska, Emőke Kiss-Tóth, Joël Ladne. Risk of eating disorders in university students: an international study in Hungary, Poland and Ukraine. International journal of adolescent medicine and health. 2020-06-18. PMID:32549156. |
students provided data about socioeconomic characteristics, body mass index (bmi), eds, physical fitness and sport practice, psychological distress (stress, anxiety, depression), life orientation, alcohol, tobacco, and cannabis use. |
2020-06-18 |
2023-08-13 |
human |
| Kei U Wong, Carl R Bau. Acute Cannabis Toxicity. Pediatric emergency care. vol 35. issue 11. 2020-04-28. PMID:31688799. |
exploratory or unintentional ingestions of cannabis-containing products (as opposed to those derived from synthetic cannabinoids, which may mimic the structure and/or function of cannabis, but are not the focus of this article) can lead to significant pediatric toxicity, including encephalopathy, coma, and respiratory depression. |
2020-04-28 |
2023-08-13 |
Not clear |
| Liat Shbiro, Danielle Hen-Shoval, Noa Hazut, Kayla Rapps, Shira Dar, Gil Zalsman, Raphael Mechoulam, Aron Weller, Gal Shova. Effects of cannabidiol in males and females in two different rat models of depression. Physiology & behavior. vol 201. 2020-04-27. PMID:30571957. |
effects of cannabidiol in males and females in two different rat models of depression. |
2020-04-27 |
2023-08-13 |
rat |
| Alexandra Butler, Karen A Patte, Mark A Ferro, Scott T Leatherdal. Interrelationships among depression, anxiety, flourishing, and cannabis use in youth. Addictive behaviors. vol 89. 2020-04-20. PMID:30321693. |
the objective of the study was to examine if depression or anxiety was associated with youth cannabis use; and investigate whether flourishing, an indicator of overall wellbeing, moderates these associations. |
2020-04-20 |
2023-08-13 |
Not clear |
| Bonnie J Leadbeater, Megan E Ames, Ashley N Linden-Carmichae. Age-varying effects of cannabis use frequency and disorder on symptoms of psychosis, depression and anxiety in adolescents and adults. Addiction (Abingdon, England). vol 114. issue 2. 2020-03-23. PMID:30276906. |
age-varying effects of cannabis use frequency and disorder on symptoms of psychosis, depression and anxiety in adolescents and adults. |
2020-03-23 |
2023-08-13 |
Not clear |
| Shahrbanoo Ghahari, Fatemeh Zandnia, Mohammad Mazloumirad, Raoofeh Ghayoomi, Bahram Gheitaran. The effectiveness of chair work intervention on anxiety and depression in divorced women using Cannabis. Asian journal of psychiatry. vol 44. 2020-03-18. PMID:31377416. |
the effectiveness of chair work intervention on anxiety and depression in divorced women using cannabis. |
2020-03-18 |
2023-08-13 |
Not clear |
| Brian A Feinstein, Christina Dyar, Dennis H Li, Sarah W Whitton, Michael E Newcomb, Brian Mustansk. The Longitudinal Associations Between Outness and Health Outcomes Among Gay/Lesbian Versus Bisexual Emerging Adults. Archives of sexual behavior. vol 48. issue 4. 2020-03-05. PMID:30519838. |
to address these gaps, the current study examined sexual orientation and gender as moderators of the longitudinal associations between outness and substance use (cigarettes, marijuana, illicit drugs, and alcohol) and mental health (depression and anxiety). |
2020-03-05 |
2023-08-13 |
Not clear |
| Mohaddeseh Ebrahimi-Ghiri, Mohammad Nasehi, Mohammad-Reza Zarrindas. Anxiolytic and antidepressant effects of ACPA and harmaline co-treatment. Behavioural brain research. vol 364. 2020-02-13. PMID:30797851. |
because the psychotropic effects and abuse liability of cannabis prevent its therapeutic application in depression and anxiety states, we decided to investigate the effects of the combination of ineffective doses of cannabinoid cb1 receptor agonist arachidonylcyclopropylamide (acpa) and β-carbolines on anxiety- and depression-related behaviors in male nmri mice. |
2020-02-13 |
2023-08-13 |
mouse |
| Tyrel J Starks, Gabriel Robles, Stephen C Bosco, Trey V Dellucci, Christian Grov, Jeffrey T Parson. The Prevalence and Correlates of Sexual Arrangements in a National Cohort of HIV-Negative Gay and Bisexual Men in the United States. Archives of sexual behavior. vol 48. issue 1. 2020-02-03. PMID:30465312. |
urban (vs. non-urban) residence moderated associations between sexual arrangements and depression as well as the use of illicit drugs other than marijuana. |
2020-02-03 |
2023-08-13 |
Not clear |
| Jack R Cornelius, Howard J Aizenstein, Tammy A Chung, Antoine Douaihy, Jeanine Hayes, Dennis Daley, Ihsan M Sallou. Paradoxical Decrease in Striatal Activation on an fMRI Reward Task Following Treatment in Youth with Co-morbid Cannabis Dependence/Major Depression. Advances in psychology research. vol 93. 2019-11-20. PMID:25904826. |
paradoxical decrease in striatal activation on an fmri reward task following treatment in youth with co-morbid cannabis dependence/major depression. |
2019-11-20 |
2023-08-13 |
human |
| Jack R Cornelius, Howard J Aizenstein, Tammy A Chung, Antoine Douaihy, Jeanine Hayes, Dennis Daley, Ihsan M Sallou. Paradoxical Decrease in Striatal Activation on an fMRI Reward Task Following Treatment in Youth with Co-morbid Cannabis Dependence/Major Depression. Advances in psychology research. vol 93. 2019-11-20. PMID:25904826. |
the aim of this study was to assess reward-related activity as shown by fmri before and after treatment among youth with comorbid cannabis dependence and major depression. |
2019-11-20 |
2023-08-13 |
human |